Novamass Ltd
Company Profile:
Novamass is a leading Nordic contract research service provider in the area of ADME (absorption, distribution, metabolism and excretion of drugs and chemicals). Our strengths are the most comprehensive in-vitro ADME service portfolio, outstanding expertise in metabolite identification, and application of Intelligent Throughput Services (ITS) ideology.
Previous Clients:
Orion Pharma, Gedeon Richter, Santen, 4SC, Affectis, KuDOS Pharmaceuticals, Respiratorius, Biolipox, CLL Pharma, Eurand, Trophos, Cyclacel, Betagenon
Key Products:
- Metabolism studies: Metabolic stability and metabolite identification
- Permeation studies: Including Caco-2, MDCK, Calu-3, BBB models and transporter interactions
- Drug interaction studies: CYP inhibition and induction, metabolising CYP and UGT enzyme identification
- In vivo ADME studies: Bioavailability, DMPK, metabolite identification
- Toxicological studies: Rodents and dogs
- Basic property characterisation: Solubility, pKa, lipophilicity, plasma stability and protein binding
Website:
www.novamass.net
